This image is not available for purchase in your country.

Moroctocog alfa blood clotting factor VIII

Moroctocog alfa blood clotting factor VIII

C046/0734

Rights Managed

51.0 MB (9.6 MB compressed)

5173 x 3449 pixels

43.7 x 29.2 cm ⏐ 17.2 x 11.5 in (300dpi)

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

DR P. MARAZZI / SCIENCE PHOTO LIBRARY DR P. MARAZZI / SCIENCE PHOTO LIBRARY

Restrictions

Editorial use only.

Caption

MODEL RELEASED. Preparation of Moroctocog alfa (trade name ReFacto), a factor VIII (FVIII) blood clotting agent for intravenous injection in a haemophiliac patient. The concentrated preparation is reconstituted before injection. Haemophilia is a hereditary disorder in which the blood clots very slowly, due to a deficiency in one of the blood coagulation factors. FVIII, also known as anti-haemophilic factor (AHF), is an essential blood clotting agent in humans.

Release details

Model release available. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Calculate price
  • Add to board